FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076917 [Registered on: 18/11/2024] Trial Registered Prospectively
Last Modified On: 15/11/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   study the effect of Amlyadhya Loham a herbo mineral formulation in Amlapitta (dyspepsia) or Hyperacidity 
Scientific Title of Study   An Analytical & Clinical Study to evaluate the effect of Amladhya Loham in Amlapitta (Dyspepsia) - An open labelled single arm study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Punya R Gangadkar 
Designation  2nd year BAMS student 
Affiliation  Sushrutha Ayurvedic Medical College and Hospital 
Address  Department of RSBK & Department of Panchakarma Room No 2 ground floor Sushrutha Ayurvedic Medical College and Hospital Bengaluru

Bangalore
KARNATAKA
560105
India 
Phone  8088694522  
Fax    
Email  punyargangadkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Punya R Gangadkar 
Designation  2nd year BAMS student 
Affiliation  Sushrutha Ayurvedic Medical College and Hospital 
Address  Department of RSBK and Department of Panchakarma Room no 2 ground floor Sushrutha Ayurvedic Medical College and Hospital Bengaluru

Bangalore
KARNATAKA
560105
India 
Phone  8088694522  
Fax    
Email  punyargangadkar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abhishek Biswas 
Designation  Assistant Professor 
Affiliation  Sushrutha Ayurvedic Medical College and Hospital 
Address  Department of RSBK Sushrutha Ayurvedic Medical College and Hospital Prashanti Kutriram Jodi Bingipura Jigani Bengaluru

Bangalore
KARNATAKA
560105
India 
Phone  9713844485  
Fax    
Email  deshubis@gmail.com  
 
Source of Monetary or Material Support  
Sushrutha Ayurvedic Medical College and Hospital Prashanti Kutiram Jodi Bingipura Jigani Bengaluru Karnataka India Pincode 560105 
 
Primary Sponsor  
Name  Sushrutha Ayurvedic Medical College and Hospital 
Address  Sushrutha Ayurvedic Medical College and Hospital Prashanti Kutiram Jodi Bingipura Jigani Bengaluru Karnataka India Pincode 560105 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Abhishek Biswas  Sushrutha Ayurvedic Medical College and Hospital  RSBK and Panchakarma OPD no. 2 ground floor Sushrutha Ayurvedic Medical College and Hospital Jigani Bengaluru
Bangalore
KARNATAKA 
9713844485

deshubis@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee (IEC) SAMCH & H-IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K30||Functional dyspepsia. Ayurveda Condition: AMLAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Amladhya Loham, Reference: Rasendra Chintamani under Amlapitta Adhikara, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Ushna Jala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  I. Classical Symptoms of Amlapitta
1. Aruchi (anorexia)
2. Gurukoshthatva (heaviness in abdomen)
3. Gaurav (lethargy)
4. Vibandh (Constipation)
5. Shiroruja (Headache)
6. Utklesh (Nausea)
7. Tiktamlodgar (Acid eructation)
8. Klama (exhaustion) and
9. Hrid- Kanta Daha (heartburn) will be considered for the study and examined on the basis of Dosha Dushya etc with a help of a special proforma after having a written consent.
II. Rome IV diagnostic criteria for Dyspepsia (Patients presenting with recurrent upper GI symptoms suggestive of dyspepsia for at least the past 6 months)
One or more of the following:
1. Bothersome postprandial fullness
2. Bothersome early satiation
3. Bothersome epigastric pain
4. Bothersome epigastric burning
AND
III. Patients with any of the following features will be evaluated clinically for other diagnoses with dyspepsia and will be ruled out (No evidence of systemic metabolic structural disease that is likely to explain the symptoms)
1. Signs or symptoms of GI bleeding.
2. Unexplained iron deficiency anemia.
3. Unintentional weight loss.
4. Palpable abdominal mass or lymphadenopathy on exam.
5. Family history of gastric cancer and no recent upper endoscopy.
6. Dysphagia.
7. Persistent vomiting.
 
 
ExclusionCriteria 
Details   Age below 18 above 60 years
 Volunteers with evidence of malignancy
 Suffering from major Systemic diseases
 Metabolic diseases other than Dyspepsia
 Chronic diseases with long run of medications
 Pregnant ladies & lactating women
 Participants currently taking medications or supplements that may affect the present study
 Participants currently enrolled in any other clinical trials or having participated in any other clinical trial in the past 30 days.
 Participants with history or currently under substance abuse.
 Any other conditions which investigator things may jeopardize the study.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess analytical properties & evaluate the therapeutic effects of Amladhya Loham in managing symptoms of Amlapitta (Dyspepsia).  0 day and 31st day 
 
Secondary Outcome  
Outcome  TimePoints 
1. To prepare Amladhya Loham
2. Evaluate the safety of Amladhya Loham
3. Analyze the changes in symptomatology & clinical parameters of Amlapitta (Dyspepsia) using Assessment Criteria for Subjective parameters
4. Assess the reduction in frequency & severity of Dyspepsia with GSRS questionnaire
 
0 day & 31st day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Amlapitta (Dyspepsia) being one of the Annavaha Strotas Dushti Vikara is a commonest disease in present era. The pooled prevalence of dyspepsia in India is estimated to be between 7.6% to 49% of the population with prevalence rate more in males in the age group of 35-501. The risk factors were age, irregular food habits, tea/coffee intake, tobacco, and alcohol consumption.2 Dyspepsia encompasses symptoms such as upper abdominal fullness, heartburn, nausea, belching, and upper abdominal pain, often occurring after eating or drinking. Although typically not life-threatening, these symptoms can significantly impact an individual’s quality of life. Prolonged reliance on antacids can have detrimental effects, leading to constipation and potentially serious complications like neurotoxicity over time. If left untreated, dyspepsia can lead to serious complications making treatment more challenging.

According to Ayurveda Mandagni (weak digestive fire), which negatively affects the Samana and Udana Vayu, as both Vayu are responsible for proper digestion. The excessive consumption of Amla (sour), Katu (spicy), Ushna (hot), and Viruddhashana (incompatible food combinations) leads to an aggravation of Pitta Dosha & gets converted into Amla Rasa (sour taste), resulting in Amlapitta.3,4

Considering its severity & serious complications; a combination of herbo-mineral cost-effective formulation i.e. Amladhya Loham mentioned in Rasendra Chintamani under Amlapitta Adhikara5 which has been said as Maha Amlapitta Nashaka is taken for study. The key ingredients, Amlaki has anti-spasmodic, anti-ulcer actions6, Pippali corrects the Apakva Pitta & has Vatanulomana action7, Loham Bhasma reduces acidic secretions, improves bowel movement8, and Sharkara Churna is Ruchya & also has properties like Daha Hrut, Vata Pittahara9, work synergistically to alleviate Pitta Dosha, correct Agni, and aid in Shamana of Amlapitta (Dyspepsia).

To check the authenticity of the formulation for its further broader usage in the market analytical study is planned. 

 
Close